A Study of Cidofovir in the Treatment of Cytomegalovirus (CMV) of the Eyes in Patients With AIDS

This study is ongoing, but not recruiting participants.

First Received: November 2, 1999 Last Updated: June 23, 2005 History of Changes

Sponsors and Collaborators:	Gilead Sciences Anderson Clinical Research
Information provided by:	NIH AIDS Clinical Trials Information Service
ClinicalTrials.gov Identifier:	NCT00002384

Purpose

Incomplete Closed Protocol

Condition	Intervention
Cytomegalovirus Retinitis HIV Infections	Drug: Cidofovir

Study Type:	Interventional
Study Design:	Treatment
Official Title:	Vistide (Cidofovir Intravenous) Treatment IND Protocol for Relapsing Cytomegalovirus Retinitis in Patients With AIDS

Resource links provided by NLM:

MedlinePlus related topics: AIDS Cytomegalovirus Infections

Drug Information available for: Cidofovir

U.S. FDA Resources

Eligibility

Ages Eligible for Study:	13 Years and older
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No

Criteria

Information not available

Contacts and Locations

No Contacts or Locations Provided

More Information

Publications:

Stagg RJ, Gathe J, Lieberman RM, Nuessle SJ, Davis JL, Ruane P, Bellman PC, Horgan M, Jaffe HS. The Vistide (cidofovir injection) treatment IND for relapsing CMV retinitis (CMV-R). Conf Retroviruses Opportunistic Infect. 1997 Jan 22-26;4th:120 (abstract no 306)

Study ID Numbers:	276A, GS-95-120, 96ACR-GIL1
Study First Received:	November 2, 1999
Last Updated:	June 23, 2005
ClinicalTrials.gov Identifier:	NCT00002384 History of Changes
Health Authority:	United States: Food and Drug Administration

Study placed in the following topic categories:

Cidofovir
Anti-Infective Agents
Sexually Transmitted Diseases, Viral
Anti-HIV Agents
Eye Diseases
Eye Infections
Acquired Immunodeficiency Syndrome
Cytomegalovirus Retinitis
Retinitis
Antiviral Agents
Cytomegalovirus
Immunologic Deficiency Syndromes

Herpesviridae Infections
Virus Diseases
Anti-Retroviral Agents
Radiation-Sensitizing Agents
HIV Infections
Sexually Transmitted Diseases
Cytomegalic Inclusion Disease
Cytomegalovirus Infections
DNA Virus Infections
Retroviridae Infections
Retinal Diseases

Additional relevant MeSH terms:

Anti-Infective Agents
Sexually Transmitted Diseases, Viral
Slow Virus Diseases
Antineoplastic Agents
Physiological Effects of Drugs
Retinitis
Infection
Anti-Retroviral Agents
Therapeutic Uses
Cytomegalovirus Infections
Retroviridae Infections
Retinal Diseases
Cidofovir
RNA Virus Infections
Anti-HIV Agents

Immune System Diseases
Eye Infections, Viral
Eye Diseases
Cytomegalovirus Retinitis
Acquired Immunodeficiency Syndrome
Eye Infections
Antiviral Agents
Immunologic Deficiency Syndromes
Pharmacologic Actions
Herpesviridae Infections
Virus Diseases
Radiation-Sensitizing Agents
HIV Infections
Sexually Transmitted Diseases
Lentivirus Infections

ClinicalTrials.gov processed this record on September 02, 2009